|
| Home : Sosei Heptares to Receive US$3 Million Payment from Genentech on Nomination of a New GPCR Disease Target |
|
Oct 09
2019 |
Sosei Heptares to Receive US$3 Million Payment from Genentech on Nomination of a New GPCR Disease Target |
|
TOKYO and LONDON, Oct. 9, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565) announces that it has been notified by its partner Genentech, a member of the Roche Group, of its desire to nominate a new G protein-coupled receptor (GPCR) disease target, which has... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/sosei-heptares-to-receive-us3-million-payment-from-genentech-on-nomination-of-a-new-gpcr-disease-target-300933864.html |
| |
|
Related News
|
» Pocket Money Goes Digital, New Study From Money.co.uk Reveals
» Volkswagen amplía aprobaciones a UL para realizar pruebas de materiales
|
|
|
